A Chlamydomonas-derived Human Papillomavirus 16 E7 vaccine induces specific tumor protection.

A Chlamydomonas-derived Human Papillomavirus 16 E7 vaccine induces specific tumor protection.

<h4>Background</h4>The E7 protein of the Human Papillomavirus (HPV) type 16, being involved in malignant cellular transformation, represents a key antigen for developing therapeutic vaccines against HPV-related lesions and cancers. Recombinant production of this vaccine antigen in an act...

Full description

Bibliographic Details
Main Authors: Olivia C Demurtas, Silvia Massa, Paola Ferrante, Aldo Venuti, Rosella Franconi, Giovanni Giuliano
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23626690/pdf/?tool=EBI

Similar Items

Similar Items